Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
Completed · Phase 2
Conditions studied: HIV Infections, Hepatitis C, Liver Disease
In brief
Infection with both HIV and hepatitis C virus (HCV) may result in serious and sometimes fatal liver disease. The purpose of this study was to test the effectiveness of long-term pegylated interferon alfa-2a (PEG-IFN) and ribavirin treatment in slowing liver disease progression in people infected with both HIV and HCV.
Key facts
- Study ID
- NCT00078403
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 333
- Starts
- 2004-07-01
- Expected to finish
- 2009-02-01
- Last updated by the study team
- 2021-11-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Alabama Therapeutics CRS — Birmingham, Alabama, United States
- University of Southern California CRS — Los Angeles, California, United States
- UCLA CARE Center CRS — Los Angeles, California, United States
- Stanford AIDS Clinical Trials Unit CRS — Palo Alto, California, United States
- UCSD Antiviral Research Center CRS — San Diego, California, United States
- Ucsf Hiv/Aids Crs — San Francisco, California, United States
- Santa Clara Valley Med. Ctr. — San Jose, California, United States
- University of Colorado Hospital CRS — Aurora, Colorado, United States
- Georgetown University CRS (GU CRS) — Washington D.C., District of Columbia, United States
- Univ. of Hawaii at Manoa, Leahi Hosp. — Honolulu, Hawaii, United States
- Northwestern University CRS — Chicago, Illinois, United States
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic — Indianapolis, Indiana, United States
- Indiana Univ. School of Medicine, Wishard Memorial — Indianapolis, Indiana, United States
- Johns Hopkins University CRS — Baltimore, Maryland, United States
- Massachusetts General Hospital CRS (MGH CRS) — Boston, Massachusetts, United States
- Brigham and Women's Hosp. ACTG CRS — Boston, Massachusetts, United States
- Beth Israel Deaconess Med. Ctr., ACTG CRS — Boston, Massachusetts, United States
- Washington University Therapeutics (WT) CRS — St Louis, Missouri, United States
- Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr. — Omaha, Nebraska, United States
- Beth Israel Med. Ctr., ACTU — New York, New York, United States
- Weill Cornell Chelsea CRS — New York, New York, United States
- NY Univ. HIV/AIDS CRS — New York, New York, United States
- Weill Cornell Uptown CRS — New York, New York, United States
- Columbia P&S CRS — New York, New York, United States
- Trillium Health ACTG CRS — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.